Market Research Logo

Ocata Therapeutics, Inc. - Product Pipeline Review - 2015

Ocata Therapeutics, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Ocata Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Ocata Therapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ocata Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ocata Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ocata Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ocata Therapeutics, Inc.’s pipeline products
Reasons to buy
  • Evaluate Ocata Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ocata Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ocata Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ocata Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ocata Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ocata Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Ocata Therapeutics, Inc. Snapshot
Ocata Therapeutics, Inc. Overview
Key Information
Key Facts
Ocata Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Ocata Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Ocata Therapeutics, Inc. - Pipeline Products Glance
Ocata Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Ocata Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Ocata Therapeutics, Inc. - Drug Profiles
MA09-hRPE
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Autoimmune Diseases
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Glaucoma
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Ophthalmic Disorders
Product Description
Mechanism of Action
R&D Progress
Stem Cell Therapy for Corneal Blindness
Product Description
Mechanism of Action
R&D Progress
Ocata Therapeutics, Inc. - Pipeline Analysis
Ocata Therapeutics, Inc. - Pipeline Products by Route of Administration
Ocata Therapeutics, Inc. - Pipeline Products by Molecule Type
Ocata Therapeutics, Inc. - Recent Pipeline Updates
Ocata Therapeutics, Inc. - Company Statement
Ocata Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Ocata Therapeutics, Inc., Key Information
Ocata Therapeutics, Inc., Key Facts
Ocata Therapeutics, Inc. - Pipeline by Indication, 2015
Ocata Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Ocata Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Ocata Therapeutics, Inc. - Partnered Products in Pipeline, 2015
Ocata Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
Ocata Therapeutics, Inc. - Out-Licensed Products in Pipeline, 2015
Ocata Therapeutics, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
Ocata Therapeutics, Inc. - Phase I, 2015
Ocata Therapeutics, Inc. - Preclinical, 2015
Ocata Therapeutics, Inc. - Discovery, 2015
Ocata Therapeutics, Inc. - Pipeline by Route of Administration, 2015
Ocata Therapeutics, Inc. - Pipeline by Molecule Type, 2015
Ocata Therapeutics, Inc. - Recent Pipeline Updates, 2015
Ocata Therapeutics, Inc., Other Locations
Ocata Therapeutics, Inc., Subsidiaries
List of Figures
Ocata Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
Ocata Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Ocata Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Ocata Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
Ocata Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report